Recomendaciones sobre el manejo del compromiso renal del lupus eritematoso sistémico: Documento de Consenso de las Sociedades Chilenas de Nefrología y Reumatología

• Verónica Aguirre ^[1] ; Miriam Alvo ^[2] ; Leopoldo Ardiles ^[1] ; J. Daniel Carpio ^[7] ; Carolina Foster ^[3] ; Annelise Goecke ^[2] ; Roberto Jalil ^[4] ; Loreto Massardo ^[4] ; Sergio Palma ^[3] ; Emilio Roessler ^[5] ; Andrés Wurgaft ^[6]
  1. [1] Universidad Austral de Chile

     Universidad Austral de Chile

     Valdivia, Chile

     
  2. [2] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  3. [3] Hospital del Salvador

     Hospital del Salvador

     Santiago, Chile

     
  4. [4] Pontificia Universidad Católica de Chile

     Pontificia Universidad Católica de Chile

     Santiago, Chile

     
  5. [5] Clínica Alemana

     Clínica Alemana

     Santiago, Chile

     
  6. [6] Clínica Las Condes

     Clínica Las Condes

     Santiago, Chile

     
  7. [7] Hospital Base Valdivia Anatomía Patológica

  Mostrar afiliaciones +
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 143, Nº. 12, 2015, págs. 1569-1578
• Idioma: español
• Títulos paralelos:
  • A consensus of the Chilean Nephrology and Rheumatology Societies on renal involvement in systemic lupus erythematosus
• Enlaces
  • Texto completo
• Resumen

  • Renal involvement affects over one half of patients with Systemic Lupus Erythematosus increasing their mortality and morbidity, including chronic renal disease and the need of renal replacement therapies. Aiming to achieve a consensus in the most relevant topics on diagnosis, therapy and follow-up of patients with lupus renal disease, the Chilean Societies of Nephrology and Rheumatology constituted a workgroup that, based on a critical review of the available literature and their experience, raised and answered by consensus a set of relevant questions. This document includes aspects related to the clinical diagnosis, the importance of a suitable histological classification, therapeutic alternatives to induce and maintain disease remission, strategies for follow-up, additional therapies and ginecological-obstetric issues.